# Omnicell

> Omnicell is a public healthcare technology company that sells medication-management hardware, software, consumables, technical support, and expert services to hospitals, health systems, retail pharmacies, and specialty-pharmacy programs. Its ambition is larger than the familiar dispensing cabinet: connect the pharmacy, nursing floor, IV room, inventory system, and outpatient medication journey so routine work is automated, stock is visible, and clinicians have fewer opportunities to make preventable mistakes.

- **Founded:** 1992
- **Headquarters:** Fort Worth, United States
- **Founders:** Randall Lipps (Founder, Chairman and CEO)
- **Team size:** Approximately 3,580 employees worldwide as of December 31, 2025
- **Products:** Titan XT, OmniSphere, XT Automated Dispensing Cabinets, Central Pharmacy Dispensing Service and XR2, IVX Station and IV Compounding Service
- **Notable:** Went public on Nasdaq in August 2001 under the ticker OMCL., Grew fiscal 2025 revenue 7% to $1.185 billion and ended the year with $636 million in annual recurring revenue., OmniSphere received HITRUST CSF i1 certification in June 2025.

## Products & services

- **Titan XT** — A next-generation enterprise automated dispensing system for nursing care areas, powered by the OmniSphere cloud platform and designed for guided restocking, centralized inventory controls, and medication-safety safeguards.
- **OmniSphere** — A cloud-native medication-management workflow and data platform designed to connect Omnicell robotics and smart devices across an enterprise.
- **XT Automated Dispensing Cabinets** — Secure point-of-care medication cabinets that track access and inventory while supporting pharmacy and nursing workflows in acute and long-term care.
- **Central Pharmacy Dispensing Service and XR2** — A combination of central-pharmacy robotics, optimization software, and onsite or remote experts that automates picking and dispensing work.
- **IVX Station and IV Compounding Service** — Robotic sterile-compounding technology and services using gravimetric controls, barcode scanning, and image recognition; Omnicell says its robots have prepared more than 13 million patient doses.
- **Inventory Optimization Service** — Analytics and role-based workflows that help health systems adjust medication inventory, reduce waste, and improve availability.
- **Specialty Pharmacy Services and 340B solutions** — Expert and software-enabled services that help health systems build and operate specialty-pharmacy programs and manage 340B workflows.
- **EnlivenHealth** — Patient-engagement, clinical, financial-workflow, and omnichannel communication software for retail pharmacies and health plans.
- **Medication adherence packaging and consumables** — Packaging automation and recurring consumables used by institutional and retail pharmacies to organize medication doses.
- **Technical and professional services** — Installation, maintenance, software support, optimization, and pharmacy expertise sold around Omnicell's installed systems.

## Achievements

- Went public on Nasdaq in August 2001 under the ticker OMCL.
- Grew fiscal 2025 revenue 7% to $1.185 billion and ended the year with $636 million in annual recurring revenue.
- OmniSphere received HITRUST CSF i1 certification in June 2025.
- Omnicell reports that its IV compounding robots have prepared more than 13 million patient doses.
- Opened an Austin Innovation Lab in May 2025 for rapid testing of customer-identified workflow solutions.
- Founder Randall Lipps was inducted into the Bellwether League Hall of Fame in 2014 for healthcare supply-chain leadership.

## Latest updates

- **2026-07** — Second-quarter revenue rose 7% year over year to $312.2 million. Omnicell increased its full-year non-GAAP profitability guidance, narrowed its revenue range, and lowered the bottom ends of its product-bookings and annual-recurring-revenue ranges.
- **2026-07** — Omnicell appointed Nnamdi Njoku president; he continues to lead operations across product, engineering, customer experience, supply chain, people, sales, and other functions.
- **2026-06** — The company selected Dan Mandoli to lead its Specialty Pharmacy Services business.
- **2026-04** — First-quarter revenue rose 15% year over year to $309.9 million; Omnicell raised its full-year non-GAAP EBITDA and EPS guidance and said Titan XT and OmniSphere customer engagement was underway.
- **2026-03** — Omnicell launched a virtual Customer Community for peer collaboration and best-practice sharing.
- **2025-12** — Omnicell launched Titan XT in the United States, with international purchase anticipated later in 2026 and ongoing OmniSphere releases expected to begin in early 2027.
- **2025-10** — Omnicell acquired ANiGENT to add clinician-designed drug-diversion surveillance and monitoring capabilities.
- **2025-06** — OmniSphere received HITRUST CSF i1 certification, and Omnicell hosted its inaugural IV TRUST Summit on sterile-compounding safety and automation.
- **2025-05** — The company opened an Innovation Lab in Austin focused on rapid experiments involving mechanics, robotics, AI, sensors, and machine vision.

## Links

- Website: https://www.omnicell.com/
- LinkedIn: https://www.linkedin.com/company/omnicell
- Twitter/X: https://twitter.com/omnicell
- YouTube: https://www.youtube.com/Omnicell1
- Facebook: https://www.facebook.com/omnicellinc/

---

Profile page: https://yespress.io/omnicell
Published by YesPress — https://yespress.io
Last updated: 2026-08-13